Giant cell arteristis and polymyalgia rheumatica: Influence of past pregnancies? The GRACG multicentric case control study;Maladie de Horton et pseudopolyarthrite rhizomélique: Influence des antécédents de grossesse? Étude cas-témoins prospective GRACG

Revue de Medecine Interne

Volumn 25, Issue 11, 2004, Pages 792-800

  Duhaut, P ^a   Abert, M C ^b   Le Page, L ^a   Bosshard, S ^c   Grunenberger, F ^b   Goichot, B ^b   Seydoux, D ^d   Pinede L ^c   Boncors, M L ^c   Loire, R ^e   Pellet, H ^c   Piette, J C ^f   Ducroix, J P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Soc de Secours Miniere de la Loire   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Giant cell arteritis; History of pregnancy; Polymyalgia rheumatica; Protective factor

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GEOGRAPHY; GIANT CELL ARTERITIS; HOSPITALIZATION; HUMAN; INTERNAL MEDICINE; MULTIVARIATE ANALYSIS; RANK SUM TEST; RHEUMATIC POLYMYALGIA; RISK; VASCULAR DISEASE; CLINICAL TRIAL; FRANCE; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PREGNANCY; PROSPECTIVE STUDY; RISK FACTOR; TEMPORAL ARTERITIS;

CASE-CONTROL STUDIES; FEMALE; FRANCE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMYALGIA RHEUMATICA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TEMPORAL ARTERITIS;

EID: 20044385566     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.07.011     Document Type: Article

References (41)

1. Bengtsson B.A., and Malmvall B.E. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidence of different clinical presentations and eye complications Arthritis Rheum 24 1981 899 904
2. Barrier J., Pion P., Massari R., Peltier P., Rojouan J., and Grolleau J.Y. Approche ́pid́miologique de la maladie de Horton dans le d́partement de Loire -Atlantique. 110:cas en dix ans (1970-1979) Rev Med Int 3 1982 13 20
3. Baldursson O., Steinsson K., Björnsson J., and Lie J.Y. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis Arthritis Rheum 37 1994 1007 1012
4. Boesen P., and Sorensen F.S. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985 Arthritis Rheum 30 1987 294 299
5. Salvarani C., Macchioni P.L., Tartoni P.L., Rossi F., Baricchi R., Castri C., Chiaravalloti F., and Portioli I. Polymalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy Clin Exp Rheum 5 1987 205 215
6. Weyand C., and Goronzy J.J. Medium- and large-vessel vasculitis New Engl J Med 349 2003 160 169
7. Barrier J., Bignon J., Soulillou J., and Grolleau J. Increased prevalence of HLA DR4 in giant cell arteritis N Engl J Med 305 1981 104 105
8. Machado E.B.V., Gabriel S.E., Beard C.M., Michet C.J., O'Fallon W.M., and Ballard D.J. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 18 1989 836 841
9. Duhaut P., Piǹde L., Demolombe-Ragú S., Loire R., Seydoux D., and Ninet J. Giant cell arteritis and cardiovascular risk factors: a multicentric, prospective case-control study Arthritis Rheum 4 1998 1960 1965
10. Salvarani C., Gabriel S.E., Balister M., and Accardo S. Increased prevalence of giant cell arteritis in Olsmted County, Minnesota: apparent fluctuations in a cylic pattern Ann Intern Med 123 1995 192 194
11. Elling P., Olsson A.T., and Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection J Rheumatol 23 1996 112 119
12. Russo M.G., Waxman J., Abdoh A.A., and Serebro L.H. Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum 38 1995 374 380
13. Duhaut P., Bosshard S., Calvet A., Piǹde L., Demolombe-Ragú S., and Dumontet C. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicentric, prospective case-control study J Rheumatol 26 1999 361 369
14. Nelson J.L. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or alloautoimmune? Arthritis Rheum 39 1996 191 194
15. Lambert N.C., Lo Y.M., Erickson T.D., Tylee T.S., and Guthrie K.A. Furst Deet al Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer Blood 100 2002 2845 2851
16. Nelson J.L. Microchimerism in human health and disease Autoimmunity 36 2003 5 9
17. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., and Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma Blood 93 1999 2033 2037
18. Duhaut P., Berruyer M., Piǹde L., Demolombe-Ragú S., Loire R., Seydoux D. for the Groupe de recherche sur l'art́rite ̀ cellules ǵantes Anticardioliopin antibodies and giant cell arteritis. A prospective, multicentric case-control study Arthritis Rheum 41 1998 701 709
19. Liozon E., Roblot P., Paire D., Loustaud V., Liozon F., and Vidal E. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58:biopsy-proven cases Rheumatology 39 2000 1089 1094
20. Duhaut P., Piǹde L., Demolombe-Ragú S., Dumontet C., Ninet J., Seydoux D. on behalf of the Gracg Giant cell arteritis and polymyalgia rheumatica: are pregnancies a protective factor? A prospective, multicentre case-control study Rheumatology 38 1999 118 123
21. McDonnell P.J., Moore G.W., Miller N.R., Hutchins G.M., and Grenn W.R. Temporal arteritis. A clinico-pathologic study Ophthalmology 93 1986 518 530
22. Smith D.C., Prentice R., Thompson D.J., and Herrmann W.L. Association of exogenous estrogen and endometrial carcinoma N Engl J Med 293 1975 1164 1167
23. Horwitz R.I., and F einstein A.R. Alternative analytic methods for case-control studies of estrogens and endometrial cancer N Engl J Med 299 1978 1089 1094
24. Cramer D.W., and Knapp R.C. Review of epidemiologic studies of endometrial cancer and exogenous estrogen Obstet Gynecol 54 1979 521 526
25. Hulka B.S., Grimson R.C., Greenberg B.G., Kaufman D.G., Fowler W.C. Jr, and Hogue C.J. "Alternative" controls in a case-control study of endometrial cancer and exogenous estrogen Am J Epidemiol 112 1980 376 387
26. Persson I., Adami H.O., Bergkvist L., Lindgren A., Pettersson B., Hoover R., and Schairer C. Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens: results of a prospective study BMJ 298 1989 147 151
27. Kaplan J.R., Adams M.R., Clarkson T.B., Manuck S.B., Shively C.A., and Williams J.K. Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models Psychosom Med 58 1996 598 611
28. Kaplan J.R., Adams M.R., Clarkson T.B., Manuck S.B., and Shively C.A. Social behavior and gender in biomedical investigations using monkeys: studies in atherogenesis Lab Anim Sci 41 1991 334 343
29. Clarkson T.B., Adams M.R., Kaplan J.R., Shively C.A., and Loritnik D.R. From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys Am J Obstet Gynecol 160 1989 1280 1285
30. Colditz G.A., Willet W.C., Stampfer M.J., Rosner B., Speizer F.E., and Hennekens C.H. A prospective study of age at menarche, parity, age at first birth, and coronary heart disease in women Am J Epidemiol 126 1987 861 870
31. Ness R.B., Harris T., Cobb J., Flegal K.M., Kelsey J.L., and Balanger A. Number of pregnancies and the subsequent risk of cardiovascular disease N Engl J Med 328 1993 1528 1533
32. Smith G.C.S., Pell J.P., and Walsh D. Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study BMJ 326 2003 423 424
33. Humphries K.H., Westendorp I.C.D., Bots M.L., Spinelli J.J., Carere R.G., and Hofman A. Parity and carotid artery atherosclerosis in elderly women. The Rotterdam study Stroke 32 2001 2259 2264
34. Lawlor D.A., Emberson J.R., Ebrahim S., Whincup P.H., Wannamethee S.G., and Walker M. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Circulation 107 2003 1260 1264 British Women's Heart and Health Study; British Regional Heart Study Findings from the British Women's Heart and Health Study and the British Regional Heart Study
35. Simon A.R., Schroder C., Martin U., Tessmann R., Templin C., and Laaf G. Induction of long-term peripheral microchimerism in non-human primates in a model of xenogeneic peripheral tolerance induction Ann Transplant 7 2002 40 45
36. Wood K.J. Passenger leukocytes and microchimerism: what role in tolerance induction? Transplantation 75 2003 17S 20S
37. Monaco A.P., and Medawar P. Chimerism in organ transplantation: conflicting experiments and clinical observations Transplantation 75 2003 13S 16S
38. Clavel-Chapelon F and E3N-EPIC Group Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women Br J Cancer 86 2002 723 727
39. Shrikhande S.N., Zodpey S.P., and Kulkarni H.R. Risk factors and protective factors of pelvic inflammatory disease: a case-control study Indian J Public Health 42 1998 42 47
40. Saftlas A.F., Levine R.J., Klebanoff M.A., Martz K.L., Ewell M.G., and Morris C.D. Abortion, changed paternity, and risk of preeclampsia in nulliparous women Am J Epidemiol 157 2003 1108 1114
41. Ahmed A., Rahman M., Zhang X., Acevedo C.H., Nijjar S., and Rushton I. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation Mol Med 6 2000 391 409